Kalaris Therapeutics: TH103 Trial Success And $50M Raise Set Stage For Growth

Kalaris Therapeutics, Inc. ( KLRS ) is set to raise $50 million in a private placement by selling about 4.2 million shares at $10 each. Now, these sales also come with pre-funded warrants for 800,000 shares. The proceedsI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation ...